Dr. Germinaro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N 39th St
Philadelphia, PA 19104Phone+1 215-662-2775
Education & Training
University of ColoradoFellowship, Clinical and Laboratory Immunology, 2011 - 2012- University of ColoradoResidency, Internal Medicine, 2009 - 2012
Lewis Katz School of Medicine at Temple UniversityClass of 2009
Certifications & Licensure
CO State Medical License 2012 - 2025
PA State Medical License 2015 - 2024- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 93 citationsGuselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.William J Sandborn, Geert R D'Haens, Walter Reinisch, Julián Panés, Daphne Chan
Gastroenterology. 2022-05-01 - 14 citationsGuselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.Laurent Peyrin-Biroulet, Jessica R Allegretti, David T Rubin, Brian Bressler, Matthew Germinaro
Gastroenterology. 2023-12-01 - 44 citationsGuselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, contro...Brian G Feagan, Bruce E Sands, William J Sandborn, Matthew Germinaro, Marion Vetter
The Lancet. Gastroenterology & Hepatology. 2023-04-01
Press Mentions
Eosinophilic Asthma Patients with Chronic Rhinosinusitis with Nasal Polyps Appear Highly ResponsiveSeptember 4th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
